DeepCure

Boston, United States

DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques.

$24.6M raised

Apr 2024

Series A

Top Investors

TLV PartnersE14 FundCreative Destruction Lab (CDL)IAG Capital PartnersMorningside

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has DeepCure raised?

DeepCure has raised $24.6M in total funding. The most recent round was Series A. The last funding was announced in April 2024.

Who are DeepCure's investors?

DeepCure's investors include TLV Partners, E14 Fund, Creative Destruction Lab (CDL), IAG Capital Partners, Morningside.

Where is DeepCure headquartered?

DeepCure is headquartered in Boston, United States.

What does DeepCure do?

DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques.

What stage is DeepCure at?

DeepCure is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 11, 2024.

MLA

"DeepCure — Funding & Investors." VCBacked, April 11, 2024, https://www.vcbacked.co/company/deepcure. Accessed June 4, 2026.

APA

VCBacked. (2024). DeepCure — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/deepcure

Wikipedia (cite web)

{{cite web |title=DeepCure — Funding & Investors |url=https://www.vcbacked.co/company/deepcure |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 11, 2024.